{
    "code": 0,
    "data": [
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimations of Revised Investor presentation",
            "news_id": "d637fab8-2e86-454c-8049-498afefbe841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba8526fd-67e9-4a90-b801-0efbe3504f4f.pdf",
            "news_date": "2026-01-28 12:02:30",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation in respect to the Board Meeting held on January 27 2026",
            "news_id": "8d3ddb55-7fe5-4a5d-b446-671a2e5e77fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3249c429-2e6c-4f5d-af4c-2501f62a0704.pdf",
            "news_date": "2026-01-27 20:32:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Result Quarter ended on December 31 2025",
            "news_id": "0958d450-a75e-4220-ad57-325bda7fdd11",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfd8c930-cd44-45ff-a474-e14a05631c0c.pdf",
            "news_date": "2026-01-27 19:51:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The company has informed about Transcript of Earnings call held on 17th October 2025.",
            "news_id": "5523e4ed-0e21-49fa-9dfe-9d714786f113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01fb77ab-399e-4201-8f6d-115fe7c69397.pdf",
            "news_date": "2025-10-24 19:24:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "news_id": "ed71c479-3041-4ccd-82d1-83287048713d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ac5e3d-7c6e-41ce-98ae-80cf42a5113a.pdf",
            "news_date": "2025-10-17 18:08:50",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "RPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Financial Result",
            "news_id": "077e01e2-d664-454d-bd14-0532969ae7b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d37dd0-303b-461b-8ac0-1ddb3fbc0dde.pdf",
            "news_date": "2025-10-17 18:00:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter ended on June 2025",
            "news_id": "1371a318-5ab2-4944-8e22-405fd0612f6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe61fba0-e96e-409d-a10b-8198353f80e5.pdf",
            "news_date": "2025-07-25 20:04:17",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited financial result for the quarter ended on June 30 2025",
            "news_id": "66a6f0ca-a697-4670-ae1c-3dc1194fb852",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d653033-6ed1-40a4-957f-7e772121ce8a.pdf",
            "news_date": "2025-07-25 19:30:47",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of letter May 29 2025 and pursuant to regulation 30 of SEBI LODR 2015 the investor presentation which will be made during the RPG Investor conference 2025 scheduled on June 3 2025.",
            "news_id": "3a470c5a-d000-47ef-96a7-4924673e281e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c2d7fe-cf03-4f5c-b358-cb15d0d163ba.pdf",
            "news_date": "2025-06-02 20:15:23",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of transcript of Results Earning Calls for Audited Financial Results for the Quarter ended on March 31 2025 held on Tuesday 29th April 2025.",
            "news_id": "d0e1f896-061f-491c-9067-8e3ccf7fb723",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a291a883-83d5-4759-b606-f11e746410f0.pdf",
            "news_date": "2025-05-05 18:29:00",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Earning Call Audio Recording Link For Q$ Ended On March 31 2025.",
            "news_body": "Intimation of audio call recording of the results earning calls for audited financial result for quarter and FY ended on March 31 2025 held today i.e. Tuesday April 29 2025.",
            "news_id": "beac9e10-36e7-4065-8ab9-b89586dc8677",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd4bb53-b211-4c19-9212-803160783b9b.pdf",
            "news_date": "2025-04-29 19:34:52",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for earning calls for quarter ended on March 31 2025.",
            "news_id": "8ae6a218-5505-491d-a7fe-653eee612b16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21a0ec4a-d895-44a4-b20c-108859d5a5d4.pdf",
            "news_date": "2025-04-29 12:27:47",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Financial Result for quarter and year ended on March 2025",
            "news_id": "6fd3260b-f375-4cf2-add8-cac893548b00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53aeab0-10c4-4eea-8227-e73b9b7732b2.pdf",
            "news_date": "2025-04-28 21:24:34",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31 2024.",
            "news_id": "d0676139-c4e3-48ce-88d5-74088fc322a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f376eacc-ae43-4469-aba8-94e97241ed6b.pdf",
            "news_date": "2025-01-28 18:12:08",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the period ended December 31 2024 are enclosed.",
            "news_id": "9a7169a0-58dc-4725-869a-b7c1100952e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ed23fab-b982-4b54-8c51-c8368059941c.pdf",
            "news_date": "2025-01-24 19:26:49",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The Transcript for the Results Earnings Call for Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024 is made available on the website of the Company.",
            "news_id": "68a5a806-0000-41f1-b4a7-3e35f79c7fa5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f61bc910-efbc-43a9-bdd4-a5e46fdb263b.pdf",
            "news_date": "2024-11-12 19:01:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby submit the weblink of audio recording of the Results Earning Call for Unaudited Financial Results of the Company for quarter and half year ended September 30, 2024",
            "news_id": "6885d0af-8a9a-46b1-9480-2976b2e2c085",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df991d3f-be69-4859-9c5d-ae5cd30bd229.pdf",
            "news_date": "2024-11-08 21:58:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024.",
            "news_id": "8b68c1ce-c0d7-471f-b018-6f7611e5a38e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2e112c0-3803-4f32-90f5-0bbd490631a1.pdf",
            "news_date": "2024-11-08 11:26:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "As per SEBI (LODR), please find attached herewith the UFR of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "695a052c-2606-4a71-a3ed-e220fbc0fbaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaad3172-b069-4059-8ef7-8467de0489da.pdf",
            "news_date": "2024-11-07 18:06:21",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Company has submitted the audio recording for the conference call for Investor/ Analyst Meeting held today.",
            "news_id": "70da20e2-404e-4ecd-b790-856f8af577ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f5760d9-e479-40ac-9b8a-2dec8ee3d46e.pdf",
            "news_date": "2024-09-18 19:15:38",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to the Unaudited Financial Results of the Company for the quarter ended June 30, 2024",
            "news_id": "5546d7f6-d030-4c91-a340-e26502a6640e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b871eab2-5f0d-49e7-8bd6-38d315753222.pdf",
            "news_date": "2024-07-27 15:57:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2024 approved and taken on record by the Board at its meeting held on July 19, 2024 along with limited Review Report signed by the Statutory Auditors of the Company",
            "news_id": "28f5c604-09b9-4cb1-9db6-446e1a7fef35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b031e64-3770-4194-b167-7f2de631ab29.pdf",
            "news_date": "2024-07-19 17:57:43",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Company has informed about Investor Presentation",
            "news_id": "c3bcb3ec-e1ea-4220-a014-64a5f7f78c1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9351c4d6-b785-4f3c-9595-5236dd084131.pdf",
            "news_date": "2024-06-06 20:08:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation to our Letters dated April 26, 2024, May 01, 2024 and May 02, 2024, the transcript of the Results Earnings call for the Audited Financial Results for the quarter and year ended March 31, 2024 held on May 02, 2024 at 3.30 p.m. IST is made available on the Company''s website.",
            "news_id": "74587323-c81d-4017-8529-70a6f8b8afbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4840999-1371-49db-a133-3c69378135a9.pdf",
            "news_date": "2024-05-08 16:55:10",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Audio recording for the earnings call for Audited FInancial Results of the Company as on March 31, 2024 is attached.",
            "news_id": "90b11cf5-0be1-443d-844f-089e084bbf5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64265712-b2ba-413d-a9cd-5aa8cf9ba131.pdf",
            "news_date": "2024-05-02 19:58:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Audited Financial Results of the Company for the quarter and year ended March 31, 2024.",
            "news_id": "d4b7a9f9-6ea1-49e4-9d72-dc531f79d143",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=448d6df6-a720-499e-82c7-6cfe76bf321b.pdf",
            "news_date": "2024-05-01 22:32:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Of The Company Held On April 30, 2024",
            "news_body": "Audited financial Results for quarter and year ended March 31, 2024.",
            "news_id": "f24c49df-da94-45df-9177-91f06de1d41e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d68a234-5f2c-4cf1-980e-7f85ba067a2a.pdf",
            "news_date": "2024-04-30 19:51:03",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023.Kindly take the same on record.",
            "news_id": "5cbeb72f-0eef-495d-b6f8-1dd3562b6234",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7335c6fe-b0de-4236-8056-7a37f026d291.pdf",
            "news_date": "2024-02-02 17:11:45",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "RPG Life Sciences Limited has informed exchanges regarding Financial results for Quarter and Nine Months ended on December 31, 2023.Kindly take the same on record.",
            "news_id": "8285fa6a-54c9-459d-910f-f82845bb2141",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4858060-17ad-4390-ae36-afcc291f2a9d.pdf",
            "news_date": "2024-02-01 17:49:53",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated October 13, 2023 and October 19, 2023, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2023, held on Thursday, October 19, 2023, at 3.30 p.m. IST. has been made available on the Company''s website.Kindly take the same on record.",
            "news_id": "253f7930-f901-48d7-b78f-6134e8cca567",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ef73901-38ca-4a78-9917-f893d2ae51d1.pdf",
            "news_date": "2023-10-25 18:22:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our Letters dated October 13, 2023 and October 19, 2023, we would like to inform you that the audio recording of the Results Earnings Call for the Unaudited FInancial Results for the quarter and half year ended September 30, 2023, held today, Thursday, October 19, 2023 at 3.30 p.m. IST has been made available on the websie of the company.Kindly take the same on record.",
            "news_id": "bf05e7ee-74a6-48fd-a268-c0a7b1a4ea39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ad4701a-8de5-4e67-843d-36ae0967f1d5.pdf",
            "news_date": "2023-10-19 19:16:48",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of investor presentation with respect to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.Kindly take the same on record.",
            "news_id": "f99c9b58-8b9e-412f-b572-82490871925f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55744826-2434-49b7-91fd-a6bb060bb964.pdf",
            "news_date": "2023-10-19 14:56:38",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "RPG Life Sciences Limited has informed the exchanges regarding Financial results for quarter and half year ended September 30, 2023.",
            "news_id": "8220126a-f106-4b6b-8f89-2a5863355deb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4275f921-60b1-4fac-b8bf-a84d00e8b2da.pdf",
            "news_date": "2023-10-18 18:23:52",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of investor presentation with respect to the Unaudited Financial Results of the Company for the quarter ended June 30, 2023",
            "news_id": "67728945-6a3c-4f98-8992-f0e13e641dce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e45abb8-d959-4d2c-bf11-a4bf23fafd03.pdf",
            "news_date": "2023-07-29 16:19:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2023 approved and taken on record by the Board of Directors at its meeting held on July 28, 2023 along with the Limited Review Report issued by the Statutory auditors of the Company.<BR> <BR> The meeting commenced at 03.00 p.m. and concluded at 05.30 p.m.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "a190f170-db66-4b55-b42f-a5bd81fa368f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b004d3a3-a935-4444-8a01-088ec1aac7d7.pdf",
            "news_date": "2023-07-28 17:58:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated April 25, 2023  and May 2, 2023, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2023, held on Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company's website at:  https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "ea4f449d-508c-4c7c-9a77-9b4c952cfe29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd82909-206a-4d47-bf7c-fb5ba3608703.pdf",
            "news_date": "2023-05-08 10:39:20",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "n continuation of our Letters dated April 29, 2023 and May 02, 2023, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2023, held today i.e. Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "a26cbdc7-1e7b-4466-a12f-220a0373fafa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=693847c8-656b-4570-8efe-98aab9a15d62.pdf",
            "news_date": "2023-05-02 20:34:06",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letter dated April 25, 2023, please find enclosed herewith Investor Presentation for the quarter and year ended March 31, 2023, for the Results Earnings call scheduled on Tuesday, May 2, 2023, at 3.30 p.m. IST. Kindly take the same on record and disseminate appropriately.",
            "news_id": "a76dad12-fd09-4744-a8a7-95cc45038af5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da31a586-b142-4325-a1d0-964c29a46200.pdf",
            "news_date": "2023-05-02 13:30:46",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: <BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion.<BR> <BR> 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.<BR> <BR> 3. Approved the Audited Financial Statements of the Company, for the year ended March 31, 2023.<BR> <BR> The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m.<BR> <BR> Kindly take the above on record.  <BR>",
            "news_id": "b0ec9180-0494-455d-a679-2c32036d0fa3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0738b9a1-53dd-43be-93a6-f541f76b2034.pdf",
            "news_date": "2023-04-28 18:54:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On April 28, 2023",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: <BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion.<BR> <BR> 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.<BR> <BR> 3. Approved the Audited Financial Statements of the Company, for the year ended  March 31, 2023.<BR> <BR> The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "4ff0a12a-66f1-4e01-be52-bec893cb2679",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=954fe354-58f8-4361-8a91-f73b83c0fd10.pdf",
            "news_date": "2023-04-28 18:50:59",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. Kindly take the same on record.",
            "news_id": "d0f1cbc5-78c9-40a0-a48e-86deab7956b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=525450c2-6566-430c-83ea-1ac92d096023.pdf",
            "news_date": "2023-02-02 12:25:48",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022.  <BR> <BR> The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "74b06829-85cc-40b2-9056-bd61cd56fae4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40b93750-2b3a-468f-8e50-2aaecbe09747.pdf",
            "news_date": "2023-02-01 17:38:43",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for   Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. <BR> <BR> The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "2ce37391-f406-49c7-8b50-ff433e2ff515",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2f4a255-c345-4b20-874d-259a513c3869.pdf",
            "news_date": "2023-02-01 17:33:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended September 30, 2022. Kindly take the same on record.",
            "news_id": "31112fa8-92bb-4bac-8314-3cb8b605f003",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb22f956-874d-468b-80d5-227b12a72d11.pdf",
            "news_date": "2022-10-31 14:17:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated October 11, 2022, October 17, 2022 and October 18, 2022, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held on Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "bc8eb64e-f84c-4429-a1d6-a8fce38871ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bd87bd6-1ad6-47af-be06-0264f6e4b1ee.pdf",
            "news_date": "2022-10-21 21:34:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our Letters dated October 11, 2022 and October 17, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held today i.e. Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "83cc9629-6ee4-4726-b17b-01a5cbdfb476",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c33e64b-698f-4a46-a263-e4a3f881b772.pdf",
            "news_date": "2022-10-18 18:34:15",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letter dated October 11, 2022, please find enclosed herewith Investor Presentation for the quarter and half year ended September 30, 2022, for the Results Earnings Call scheduled on Tuesday, October 18, 2022, at 3.30 p.m. IST. Dial-in details of which are reproduced below for ready reference.Kindly take the same on record and disseminate appropriately.",
            "news_id": "4563d0d2-7a59-44ac-b2a1-b63193eda0ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=481b0f6b-f09a-40c9-aa2e-2f24fe2a1ce9.pdf",
            "news_date": "2022-10-17 20:09:25",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Monday, October 17, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "6dba54dd-714b-41f7-abdb-335f66889e16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b4cb704-0917-483d-aa74-b4fa3cce37d7.pdf",
            "news_date": "2022-10-17 18:43:16",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Monday, October 17, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "1f9cdee1-06ce-46a9-a102-968c78af307d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf3fd384-4482-4337-880d-74a8ce993885.pdf",
            "news_date": "2022-10-17 18:38:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our Letter dated September 12, 2022, please find enclosed herewith the Investor's Presentation which will be made during RPG Annual Investor Conference 2022.Kindly take the same on record.",
            "news_id": "cfbd5226-05ee-4402-8c8e-d02865eaaec9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1258daac-eba7-49b9-ac8b-fae5f124b9a2.pdf",
            "news_date": "2022-09-13 18:52:54",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2022. Kindly take the same on record.",
            "news_id": "ffbdfaaa-e210-4918-b865-75cad21d96e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efac7750-bc9a-4bee-a245-aad97eb8ef0d.pdf",
            "news_date": "2022-08-04 20:25:11",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2022 which were approved by the Board of Directors of the Company, at its meeting held on August 02, 2022 along with Limited Review  Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:00 p.m.<BR> <BR> Kindly take the above on your record.<BR>",
            "news_id": "f9732b72-a919-4d01-9950-f48ad3de82f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1967151a-bb58-4ef4-a391-532c8ea4cca8.pdf",
            "news_date": "2022-08-02 18:17:06",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2022. Kindly take the same on record.",
            "news_id": "09d89f24-d3d8-42f4-a538-58acb0bee7d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d074bd23-95b1-4141-80fe-0d674ef0526f.pdf",
            "news_date": "2022-05-11 18:01:24",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated April 25, 2022, April 29, 2022, April 30, 2022 and May 2, 2022, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2022, held on Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at:  https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "34c82624-6d57-40fc-829b-4ed2bed0f414",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e41bf79c-a756-4806-9108-5954290ee72a.pdf",
            "news_date": "2022-05-05 17:13:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our Letters dated April 25, 2022, April 29, 2022 and April 30, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2022, held today i.e. Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "121a9170-e7c3-4cf0-852b-e30f70e13e67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44970c71-bea6-4677-825e-71bbbd3d9d54.pdf",
            "news_date": "2022-05-02 19:13:51",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letters dated April 25, 2022 and April 29, 2022, please find enclosed herewith Investor Presentation for the quarter and year ended March 31, 2022, for the Results Earnings call scheduled on Monday, May 2, 2022, at 3.30 p.m. IST. Dial-in details of which are reproduced below for ready reference.",
            "news_id": "d048b23a-8202-43f2-aef2-5fbb251dedb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af5d09e-bde8-4361-9930-2dc8eeaba88f.pdf",
            "news_date": "2022-04-30 22:58:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2022, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 29, 2022 along with Auditors Report thereon with unmodified opinion.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.",
            "news_id": "129a4107-e931-4e3f-88b7-4fb8d5cfe751",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b654768e-c84d-4528-af7d-441e4d8aeacc.pdf",
            "news_date": "2022-04-29 18:21:45",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for   Outcome Of The Board Meeting Held On April 29, 2022",
            "news_body": "Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.",
            "news_id": "b302680e-712b-459d-9adf-61e064a44ec7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3b564c5-7f82-43aa-98a1-6d1fdca3af16.pdf",
            "news_date": "2022-04-29 18:18:32",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021. Kindly take the same on record.",
            "news_id": "2f7d912c-7be8-474f-8d7b-94df57355044",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecf5e01c-3b3f-468f-9fce-7803e6ab0929.pdf",
            "news_date": "2022-01-29 17:22:29",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2021 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2022 along with Limited Review Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "f0aa8226-1c78-4b01-9e86-952400e142c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa50dab7-7462-42b4-af4d-a703d585758a.pdf",
            "news_date": "2022-01-25 17:29:40",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letters dated October 20, 2021, October 29, 2021 and November 1, 2021, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021, held on Monday, November 1, 2021 at 4.00 p.m. IST has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.php. <BR> <BR> Kindly take the same on record and disseminate appropriately. <BR>",
            "news_id": "d5ed5aef-741c-4308-9cc5-d9eace400ed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4636db0a-3861-4229-9f86-cd3d165dd31d.pdf",
            "news_date": "2021-11-08 20:28:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our letters dated October 20, 2021 and October 29, 2021, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021, held today i.e. on Monday, November 1, 2021 at 4.00 p.m. IST has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.php <BR> <BR> Kindly take the same on record and disseminate appropriately. <BR>",
            "news_id": "83361c2b-d07f-48bc-a8f0-bdb95950051e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e9a3134-0b82-4a74-8c3a-b421bd2a704e.pdf",
            "news_date": "2021-11-01 20:41:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the quarter and half year ended September 30, 2021 and details of the Results earnings call.",
            "news_id": "0510c023-1343-43ad-a260-960951995d33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691e13cb-c1a2-4421-9604-cbb17fabe9d7.pdf",
            "news_date": "2021-10-29 19:59:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and half year ended September 30, 2021 which were approved by the Board of Directors of the Company, at its meeting held on October 29, 2021 along with Limited Review Report issued by the Statutory Auditors of the Company. <BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:20 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "d649c018-f1b1-476a-91a1-d46baf1b4931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b84bc54b-3d11-4fa1-be16-f497f9aec985.pdf",
            "news_date": "2021-10-29 17:31:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2021 which were approved by the Board of Directors of the Company, at its meeting held on July 28, 2021 along with Limited Review  Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:00 p.m.<BR> <BR> Kindly take the above on your record.<BR>",
            "news_id": "f49c3cc6-e153-4ef5-8c32-3846529e5366",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36481263-9ee3-459d-b51d-438601151f76.pdf",
            "news_date": "2021-07-28 17:21:57",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our letters dated June 9 and June 14, 2021, we would like to intimate that the recording of the Company's session at the RPG Annual Investor Conference 2021 has been voluntarily made available at the Investors section of the Company's website i.e. https://www.rpglifesciences.com/website/investor_presentations.php <BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "998dba07-caf8-4668-b51c-4fc842bbd918",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=207bfc13-e8c6-4012-b912-9c8a61468d23.pdf",
            "news_date": "2021-06-26 10:34:26",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2021. <BR> Kindly take the same on record.<BR>",
            "news_id": "985402f4-c463-44c0-856e-85927e785871",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf2cccb8-83b1-40a0-b8a3-3c5b96257581.pdf",
            "news_date": "2021-05-25 18:11:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2021, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 30, 2021 along with Auditors Report thereon with unmodified opinion.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.   <BR>",
            "news_id": "a6ea6df3-ff16-481f-9c8b-d64d5cc11f0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feef452d-2d72-4829-9ac2-2aee23759baa.pdf",
            "news_date": "2021-04-30 18:21:30",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}